PTPRF and Burkitt lymphoma: By contrast, larger bulk transcriptomic analyses generally report BL tumors as comparatively stroma-low, with lower CD10+/GPR77+ CAF abundance, along with lower overall stromal signatures than M or LAR subtypes [21], highlighting potential subtype- and method-related discrepancies.